|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Regeneration of ethyl parathion antibodies for repeated use in immunosensor: a study on dissociation of antigens from antibodies 显示文摘 | kandimalla V B Neeta N S Karanth N G | 2004 | Biosensors & Bioelectronics2004，，20： | 1 |
| 2 | Fabrication of nanofibers with antimicrobial functionality used as filters: protection against bacterial contaminants 显示文摘 | NEETA L L RAMAKRISHNAN R LI B | 2007 | Biotechnology and Bioengineering2007，97，6： | 1 |
| 3 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 4 | Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer*显示文摘 | Apolo Andrea B Pandit-Taskar Neeta Morris Michael J | 2008 | The Journal of Nuclear Medicine2008，，12： | 1 |
| 5 | Improvement of quality and shelf-life of strawberries with edible coatings enriched with chitosan显示文摘 | Neeta B G Pooja R P Ramana R | 2013 | Postharvest Biology and Technology2013，85，10： | 1 |
| 6 | Regeneration of ethyl parathion antibodies for repeated use in immunosensor a study on dissociation of antigens from antibodies显示文摘 | Kandinalla V B Neeta N S Karanth N G | 2004 | Biosensors and Bioelectronics2004，，20： | 1 |
| 7 | Bismuth nitrate-catalyzed versatile Michael reactions显示文摘 | NEETA S BIMAL K B | 2003 | J Org Chem2003，68，： | 1 |
| 8 | Dialysate iron therapy:Infusion of solu- ble ferric pyrophosphate via the dialysate during hemodialysis 显示文摘 | Ajay G Neeta B Amin AB | 2010 | Kidney interna- tional2010，55，： | 1 |
| 9 | Bismuth nitrate catalyzed versatile Michael reactions 显示文摘 | Neeta S Bimal K B | 2003 | Journal Organic Chemistry2003，68，： | 1 |
| 10 | Breeding and biotechnological efforts in Jatropha curcas L.for sustainable yields显示文摘Jatropha is a non-edible,important bioenergy plant,which can grow in marginalized land.The seeds possess about 36%oil and this would be converted into biodiesel or biojet-fuel.Jatropha provides an option for sustainable feed and fuel production due to its inherent qualities including hardy nature,drought tolerance and surviving with limited amount of water,tolerance to unfavorable conditions and excessive moisture.However,heterozygosity,low productivity and poor understanding of its genome are the major impediments to elite line development.Further,classical breeding and advanced technological investments remain limited owing to long juvenile phase and breeding cycles.Scientific technologies that lead to identification of elite genotypes and development of high yielding elite Jatropha lines and effective methods of detoxification of seeds needs immediate priority.Efficient tissue culture system,doubled haploids(DH)and genomic tools are increasingly made available to improve the seed yield and its oil quantity through the development of geminivirus disease resistant lines.The application of advanced,sequencing technologies has presented a repertoire of genomic information for this important yet orphan crop.In the present investigation,we highlight the achievements made in Jatropha towards development of high yielding,virus resistant elite lines and hybrids with yield potential ranging from 3 to 5 tons per hectare in a year,which is a first ever report in the world.We also developed potential biotechnological tools such as genetic transformation,genome editing and next generation genomics tools including linkage maps and QTLs for accelerating breeding efforts through marker assisted selection.Because of our concerted and continuous efforts during the past 15 years,we have overcome all the obstacles and developed high yielding,disease resistant hybrids/lines,advanced cultivation technologies with thorough knowledge on Agronomy of the Jatropha crop.The Jatropha cultivation technology developed for the first time in the world,could open up new avenues for higher yield productivity of commercial viability. | S.Arockiasamy Jyothirmayi Kumpatla Sainath Hadole Vijay Yepuri Manoj Patil Vineeta Shrivastava Chandrasekhara Rao Nagesh Kancharla Saakshi Jalali Alok Varshney Neeta Madan Sai Pothakani Vinod Nair Sridhar Peyyala Vishwnadharaju Mudunuri Ananthan Gopal Niranjan S.Kumar Jawahar Pachiyannan Satyanarayana Seelamanthula J.V.Narasimham Makarand Phadke Anindya B Ajit Sapre Santanu Dasgupta | 2021 | Oil Crop Science2021，6，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员